Sutor D J, Percival J M
Gut. 1976 Jul;17(7):506-10. doi: 10.1136/gut.17.7.506.
When calcium and phosphate ions were mixed so that their final concentration was 4 mmol/1 and the pH was kept at 7-0, an amorphous precipitate immediately formed and this changed into crystalline material with an apatite-like structure after a period of time. The formation of either or both types of precipitate could be slowed down or prevented by adding to the crystallising medium trace amounts of pyrophosphate or citrate which are known inhibitors of the formation of calcium phosphate, or large quantities of sodium chloride which increased the ionic strength of the solution and hence the solubility of calcium phosphate, Both common duct and gallbladder bile from patients with gallstones composed of cholesterol and/or calcium carbonate had a very pronounced inhibitory action on the formation of these precipitates. Only very small amounts of bile were necessary to produce these effects, which therefore were not due to an increase in ionic strength. Ultrafiltration of bile showed that material with a molecular weight greater than 10 000 was mainly responsible for this activity. Because the inhibitor was present in both common duct and gallbladder bile, the liver is the likely source of origin. The possible identity of this material is examined. The powerful inhibitory effect of bile on the crystallisation of calcium phosphate is probably a contributory factor to the rare occurrence of the calcium phosphates, apatite and whitlockite, in gallstones.
当钙离子和磷酸根离子混合,使其最终浓度为4 mmol/L且pH值保持在7.0时,会立即形成无定形沉淀,一段时间后该沉淀会转变为具有磷灰石样结构的晶体物质。通过向结晶介质中添加痕量焦磷酸盐或柠檬酸盐(已知的磷酸钙形成抑制剂),或大量氯化钠(增加溶液的离子强度,从而提高磷酸钙的溶解度),可以减缓或阻止这两种沉淀的形成。患有由胆固醇和/或碳酸钙组成胆结石的患者的胆总管胆汁和胆囊胆汁对这些沉淀的形成都有非常显著的抑制作用。产生这些作用只需要极少量的胆汁,因此这些作用并非由于离子强度增加所致。胆汁的超滤显示,分子量大于10000的物质是造成这种活性的主要原因。由于抑制剂同时存在于胆总管胆汁和胆囊胆汁中,肝脏可能是其来源。本文对该物质可能的特性进行了研究。胆汁对磷酸钙结晶的强大抑制作用可能是胆结石中罕见出现磷酸钙、磷灰石和白磷钙矿的一个促成因素。